Recruiting Pulmonary Hypertension Studies in Washinton
About Pulmonary Hypertension Clinical Trials in Washinton
Pulmonary hypertension is a type of high blood pressure that affects the arteries in the lungs and the right side of the heart. It can lead to heart failure if untreated. Treatment includes vasodilators, endothelin receptor antagonists, and PDE-5 inhibitors.
There are currently 1 pulmonary hypertension clinical trials recruiting participants in Washinton, DC. These studies are seeking a combined 200 participants. Research is being sponsored by Medstar Health Research Institute. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pulmonary Hypertension Clinical Trials in Washinton — FAQ
Are there pulmonary hypertension clinical trials in Washinton?
Yes, there are 1 pulmonary hypertension clinical trials currently recruiting in Washinton, DC. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Washinton?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Washinton research site will contact you about next steps.
Are clinical trials in Washinton free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Washinton studies also compensate for your time and travel.
What pulmonary hypertension treatments are being tested?
The 1 active trials in Washinton are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary hypertension.
Data updated July 13, 2026 from ClinicalTrials.gov